http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980318-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 |
| filingDate | 2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103980318-B |
| titleOfInvention | Nucleoside phosphate prodrug containing substituted benzyl, its preparation method and use |
| abstract | The invention relates to a novel nucleoside phosphate prodrug containing a substituted benzyl group and its preparation method and application. The novel nucleoside phosphate prodrug containing substituted benzyl is a compound shown in formula (I) or formula (II) or its isomer or pharmaceutically acceptable salt, which can be used as various nucleoside analogs, For example, prodrugs of acyclic nucleosides, carbocyclic nucleosides, and furanic nucleosides can enhance the biological activity of nucleoside compounds, and thus be used in the treatment of viral infections and cancer. |
| priorityDate | 2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 365.